Knome, Inc., a recognized pioneer in the personal genomics field, today announced the launch of KnomeDISCOVERY, the first fully integrated human genome sequencing and data processing service for researchers. The new offering meets rapidly emerging demand from biomedical researchers for a one-stop service that bundles affordable, research-tailored access to a broad range of next-generation sequencing platforms with discovery-supportive data management and analysis. KnomeDISCOVERY is expected to catalyze important genetic insights into rare and common human diseases, and to accelerate the development of effective treatments.
In 2007, only three complete human genomes were available for research. In 2010, by contrast, Knome expects to see the sequencing of thousands of genomes as government and private foundations invest hundreds of millions of dollars in grants to leverage the empirical power of individual genome sequencing.
As the cost of sequencing drops, and the tide of genome data rises, data management and analysis are emerging as pressure points that require significant computational infrastructure and expertise. Through KnomeDISCOVERY, individual research groups can leverage Knome's unparalleled sequencing platform access and experience in whole genome and exome analysis.
The new service is ideal for two types of researchers: